President Donald Trump arrived Friday in Texas for a firsthand look at the devastation from the state's catastrophic flooding ...

The new dosing schedule with a more gradual titration significantly lowered incidence of ARIA-E in the TRAILBLAZER-ALZ 6 trial.

The Department of Health and Human Services said it will reclassify those programs as federal public benefits, restricting ...

A new dosing regimen for Kisunla, to help lower the risk of certain side effects, has been approved by the U.S. Food and Drug ...

A journey through the FDA’s newly released complete response letters gave glimpses into the journeys to market for Eli ...